HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.